About NANO MRNA
NANO MRNA is evolving a cycle of mRNA medicine IP generation-licensing as a platform company that connects drug discovery seeds with medical and drug development needs.
Corporate Profile
| Corporate Nam | NANO MRNA Co.,Ltd. |
|---|---|
| Location |
Office6F NOVEL WORK Kanda, 2-10-4 Kanda Tsukasamachi, Chiyoda-ku, Tokyo 101-0048, Japan |
| Subsidiary Company | PrimRNA Co., Ltd. |
| Luna RD co., ltd. | |
| Establishment | April 1, 2026 |
| Capital | JPY 90 million (As of April 1, 2026) |
| Director |
President & Representative DirectorShiro Akinaga DirectorDaisuke Nakashima DirectorNorihiko Shiraishi DirectorNobuhiro Todokoro Corporate AuditorSeiichiro Wada |
| Scopes of Business | R&D and production of pharmaceuticals using micellar nanoparticles technology. |